Follow
Tine Tricot
Tine Tricot
Project manager, Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KULeuven CCB
Verified email at kuleuven.be
Title
Cited by
Cited by
Year
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
W Guo, M Naujock, L Fumagalli, T Vandoorne, P Baatsen, R Boon, ...
Nature communications 8 (1), 861, 2017
3422017
Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines
R Boon, M Kumar, T Tricot, I Elia, L Ordovas, F Jacobs, J One, J De Smedt, ...
Nature communications 11 (1), 1393, 2020
1012020
Comparing in vitro human liver models to in vivo human liver using RNA-Seq
R Gupta, Y Schrooders, D Hauser, M van Herwijnen, W Albrecht, ...
Archives of toxicology 95, 573-589, 2021
642021
Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
R Ramezankhani, R Solhi, A Memarnejadian, F Nami, SMR Hashemian, ...
International journal of antimicrobial agents 56 (6), 106208, 2020
382020
Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals
T Tricot, N Helsen, SJF Kaptein, J Neyts, CM Verfaillie
PloS one 13 (12), e0209097, 2018
222018
Recent advances in lineage differentiation from stem cells: hurdles and opportunities?
J Terryn, T Tricot, M Gajjar, C Verfaillie
F1000Research 7, 2018
222018
A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model
M Kumar, B Toprakhisar, M Van Haele, A Antoranz, R Boon, F Chesnais, ...
Biomaterials 276, 121006, 2021
212021
Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes
AM Patel, K Wierda, L Thorrez, M van Putten, J De Smedt, L Ribeiro, ...
Translational psychiatry 9 (1), 200, 2019
182019
Alternative cell sources for liver parenchyma repopulation: where do we stand?
T Tricot, J De Boeck, C Verfaillie
Cells 9 (3), 566, 2020
162020
Current status and challenges of human induced pluripotent stem cell-derived liver models in drug discovery
T Tricot, CM Verfaillie, M Kumar
Cells 11 (3), 442, 2022
152022
CRISPR/Cas9 screen in human iPSC‐derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity
W Guo, H Wang, A Kumar Tharkeshwar, J Couthouis, E Braems, ...
Alzheimer's & Dementia 19 (4), 1245-1259, 2023
132023
HiPSC-derived hepatocyte-like cells can be used as a model for Transcriptomics-based study of chemical toxicity
S Ghosh, J De Smedt, T Tricot, S Proença, M Kumar, F Nami, ...
Toxics 10 (1), 1, 2021
72021
Patient-specific induced pluripotent stem cell-derived hepatocyte-like cells as a model to study autosomal recessive hypercholesterolemia
P Nikasa, T Tricot, N Mahdieh, H Baharvand, M Totonchi, MS Hejazi, ...
Stem Cells and Development 30 (14), 714-724, 2021
72021
Metabolically improved stem cell derived hepatocyte-like cells support HBV life cycle and are a promising tool for HBV studies and antiviral drug screenings
T Tricot, HJ Thibaut, K Abbasi, R Boon, N Helsen, M Kumar, J Neyts, ...
Biomedicines 10 (2), 268, 2022
32022
A Novel UPLC-MS metabolomic analysis-based strategy to monitor the course and extent of iPSC differentiation to hepatocytes
M Moreno-Torres, M Kumar, G Garcia-Llorens, G Quintas, T Tricot, ...
Journal of Proteome Research 21 (3), 702-712, 2022
32022
HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity. Toxics 2022, 10, 1
S Ghosh, J De Smedt, T Tricot, S Proença, M Kumar, F Nami, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–16